Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations

Show other versions (1)

Detalles Bibliográficos
Main Authors:	Hanekom, W, Dockrell, H, Ottenhoff, T, Doherty, T, Fletcher, H, McShane, H, Weichold, F, Hoft, D, Parida, S, Fruth, U
Formato:	Journal article
Idioma:	English
Publicado:	Public Library of Science 2008
Subjects:	Medical sciences Vaccinology Infectious diseases

Títulos similares

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
por: Hanekom, W, et al.
Publicado: (2008)

Immunological outcomes of new tuberculosis vaccine trials: WHO panel recommendations.
por: Willem A Hanekom, et al.
Publicado: (2008-07-01)

Evaluation of a human BCG challenge model to assess antimycobacterial immunity induced by BCG and a candidate TB vaccine, MVA85A, alone and in combination
por: Harris, S, et al.
Publicado: (2013)

Immunogenicity and induction of immunological memory of the heptavalent pneumococcal conjugate vaccine in preterm UK infants
por: Ruggeberg, J, et al.
Publicado: (2007)

Inflammatory and myeloid-associated gene expression before and one day after infant vaccination with MVA85A correlates with induction of a T cell response.
por: Matsumiya, M, et al.
Publicado: (2014)

Evaluation of the immunological mechanisms induced by mycobacteria and the potential effect this may have on immunity induced by tuberculosis vaccines
por: Poyntz, HC
Publicado: (2012)

Editorial: Reverse Vaccinology
por: Richard Moxon, et al.
Publicado: (2019-12-01)

A simplified 4-site economical intradermal post-exposure rabies vaccine regimen: a randomised controlled comparison with standard methods
por: Warrell, M, et al.
Publicado: (2008)

Disease susceptibility to ST11 complex meningococci bearing serogroup C or W135 polysaccharide capsules, North America
por: Pollard, A, et al.
Publicado: (2004)

Development of antimalarial human monoclonal antibodies against Plasmodium falciparum
por: Wang, LT
Publicado: (2022)

Understanding vaccine induced protective immunity to Mycobacterium tuberculosis
por: Ronan, E
Publicado: (2011)

Understanding the link between interleukin 17 and vaccine-induced protection in tuberculosis
por: Griffiths, K
Publicado: (2012)

Innate immune responses to tuberculosis vaccines
por: Matsumiya, M
Publicado: (2014)

B cell responses to conjugate and polysaccharide meningococcal vaccines
por: Ramasamy, M
Publicado: (2012)

Malaria pre-erythrocytic stage vaccines: targeting antigen combinations
por: Bauza, K
Publicado: (2012)

New approaches for improving the immunogenicity of modified vaccinia virus Ankara as a recombinant vaccine vector
por: Alharbi, N
Publicado: (2014)

Host genetic factors and vaccine-induced immunity to hepatitis B virus infection
por: Hennig, B, et al.
Publicado: (2008)

Characterising immune responses to viral vectored vaccines against influenza and hepatitis C
por: Antrobus, R
Publicado: (2014)

Data Behind Vaccine Hesitancy and Latest Updates on Vaccines in the Pipeline—2019 Annual Conference on Vaccinology Research, April 3–5, 2019
por: William Schaffner, et al.
Publicado: (2020-01-01)

Control of typhoid fever: evaluating herd protection through public health use of typhoid VI polysaccharide vaccine
por: Ochiai, R
Publicado: (2011)

Antibody-based HIV-1 vaccines: recent developments and future directions
por: Montefiori, D, et al.
Publicado: (2007)

Analysis of b cell responses to blood-stage malaria antigens in humans following immunization with candidate vaccines and controlled human malaria infection
por: Elias, SC
Publicado: (2014)

The Vaccinia Virus A36R Protein Is a Type Ib Membrane Protein Present on Intracellular but Not Extracellular Enveloped Virus Particles
por: Van Eijl, H, et al.
Publicado: (2000)

Novel adenoviral vectored vaccines and the implications of viral diversity in therapeutic strategies against Hepatitis C Virus infection
por: Kelly, C
Publicado: (2013)

Epitope dominance studies with serotype O foot-and-mouth disease
por: Borley, DW
Publicado: (2012)

Long term efficacy of a pre-erythrocytic malaria vaccine and correlates of protection in children residing in a malaria endemic country
por: Olotu, A
Publicado: (2013)

Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
por: Ahmed, T, et al.
Publicado: (2014)

HIV-specific interleukin-10 responses and immune modulation
por: Clutton, G
Publicado: (2012)

Vaccines for the 21st century
por: Isabel Delany, et al.
Publicado: (2014-05-01)

The role of lung tissue-resident memory T cells in protection against tuberculosis
por: Bull, N
Publicado: (2017)

The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
por: Wan, L, et al.
Publicado: (2012)

Evaluation of a potential vaccine against hyperinvasive serogroup B Neisseria meningitidis by assessment of the effects of surface-expressed Opacity-associated proteins on the immune system
por: Sadarangani, M
Publicado: (2011)

Architecture of the HIV-1 glycan shield
por: Pritchard, L
Publicado: (2014)

T-cell receptor (TCR) usage in HIV-2 infection
por: Moysi, E
Publicado: (2012)

Enhancing the efficacy of viral vector blood-stage malaria vaccines
por: Forbes, E
Publicado: (2011)

Haemophilus influenzae Type b vaccine failure in children is associated with inadequate production of high-quality antibody
por: Lee, Y, et al.
Publicado: (2008)

Editorial: Precision vaccinology for infectious diseases
por: Mahbuba Rahman, et al.
Publicado: (2024-04-01)

Vaccine Evolution and Its Application to Fight Modern Threats
por: Emanuele Andreano, et al.
Publicado: (2019-07-01)

Evaluation of the immunogenicity of a promising vaccine regimen to identify immune correlates of protection
por: Pinpathomrat, N
Publicado: (2018)

Global epidemiology of meningococcal disease and vaccine efficacy
por: Pollard, A
Publicado: (2004)